Results 221 to 230 of about 14,672,329 (357)
Pathogen defence is a potential driver of social evolution in ambrosia beetles. [PDF]
Nuotclà JA, Biedermann PHW, Taborsky M.
europepmc +1 more source
Dormant cancer cells can hide in distant organs for years, evading treatment and the immune system. This review highlights how signals from the surrounding tissue and immune environment keep these cells inactive or trigger their reawakening. Understanding these mechanisms may help develop therapies to eliminate or control dormant cells and prevent ...
Kanishka Tiwary +1 more
wiley +1 more source
Social evolution of innate immunity evasion in a virus. [PDF]
Domingo-Calap P +3 more
europepmc +1 more source
This study shows that lung adenocarcinomas exploit developmental branching morphogenesis to acquire a therapy resistant basal‐like tumour cell state. This process was found to be regulated by combined TP53 loss‐of‐function and type‐I interferon signalling, identifying a novel axis for biomarker and therapeutic target discovery.
Kamila J Bienkowska +13 more
wiley +1 more source
Pleiotropy, cooperation, and the social evolution of genetic architecture. [PDF]
Dos Santos M, Ghoul M, West SA.
europepmc +1 more source
The Emergence and Evolution of Doctor of Social Work Programs (DSW): A Review of DSW Education, Student Outcomes, and Implications for the Profession [PDF]
Cynthia Franklin +2 more
openalex
Combining osimertinib with the STING agonist ADU‐S100 activates innate and adaptive immunity to overcome the non‐inflamed microenvironment of Egfr‐mutant lung cancer. This combination increases NK and CD8+ T‐cell infiltration, associated with activation of the STING‐IRF3 pathway and local immunogenic cell death.
Jun Nishimura +19 more
wiley +1 more source
Rate variation in the evolution of non-coding DNA associated with social evolution in bees. [PDF]
Rubin BER, Jones BM, Hunt BG, Kocher SD.
europepmc +1 more source
Pair‐wise comparison of the CellSearch and FETCH enrichment technologies for circulating tumor cells (CTCs) from metastatic breast, prostate, and small cell lung cancer patients shows an increased capture of CTCs using FETCH enrichment. The clinical implementation of circulating tumor cells (CTCs) as a predictive tool for therapy efficacy in the ...
Michiel Stevens +6 more
wiley +1 more source

